Review
Published on 15 Nov 2023
The power of phages: revolutionizing cancer treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1290296
- 11,006 views
- 13 citations
Type at least 3 characters
1,390 articles
Articles
Review
Published on 09 Nov 2023
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1244781
- 4,510 views
- 10 citations
Original Research
Published on 09 Nov 2023
Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1231094
- 2,079 views
Case Report
Published on 08 Nov 2023
Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1249453
- 1,632 views
- 2 citations
Editorial
Published on 08 Nov 2023
Editorial: Immune-related adverse events for patients with lung cancer-volume II
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1282394
- 1,076 views
Review
Published on 03 Nov 2023
Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1275076
- 5,213 views
- 3 citations
Editorial
Published on 01 Nov 2023
Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1301340
- 1,105 views
Original Research
Published on 01 Nov 2023
Genomic profiling and immune landscape of olfactory neuroblastoma in China
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1226494
- 2,354 views
- 5 citations
Original Research
Published on 30 Oct 2023
PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1207551
- 2,361 views
Original Research
Published on 27 Oct 2023
Cuproptosis in ccRCC: key player in therapeutic and prognostic targets
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1271864
- 2,762 views
- 1 citation
Original Research
Published on 27 Oct 2023
Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1186101
- 2,357 views
- 3 citations
Systematic Review
Published on 26 Oct 2023
Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1181248
- 2,711 views
- 6 citations
Original Research
Published on 26 Oct 2023
Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1211103
- 1,371 views
- 2 citations
Original Research
Published on 24 Oct 2023
Identification and characterization of interferon-Îł signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1227606
- 3,108 views
- 3 citations
Mini Review
Published on 24 Oct 2023
Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1210297
- 4,412 views
- 5 citations
Editorial
Published on 23 Oct 2023
Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1301416
- 910 views